Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2002 Sep;73(3):261–266. doi: 10.1136/jnnp.73.3.261

Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease

D Liolitsa 1, J Powell 1, S Lovestone 1
PMCID: PMC1738023  PMID: 12185156

Abstract

Objective: To test the hypothesis that polymorphic variation in insulin signalling genes may underlie the shared risk of dysfunctional insulin signalling and late onset Alzheimer's disease (AD). The p85α subunit of phosphatidyl inositol 3 kinase (PIK3R1) and the regulatory subunit 3 of protein phosphatase 1 (PPP1R3) were selected as candidate genes because both encode key proteins involved in insulin signalling and because polymorphisms in these genes have been previously implicated in insulin resistance or type II diabetes.

Methods: Analysis of the Met326Ile PIK3R1 and the Asp905Tyr PPP1R3 polymorphisms in 202 patients with late onset AD and 160 or 170 age matched normal subjects.

Results: Logistic regression analysis using the recessive genetic model showed significant differences in genotype and allelic frequencies between the AD group and normal controls (genotypes: odds ratio (OR) 2.09, 95% confidence interval (CI) 1.17 to 3.74, p = 0.01; alleles: OR 1.99, 95% CI 1.17 to 3.40, p = 0.01) for the Met326Ile PIK3R1 polymorphism that were female specific. Additionally, in the dominant genetic model a marginally significant association in genotype frequencies between the Asp905Tyr PPP1R3 polymorphism and AD was observed (genotypes: OR 1.85, 95% CI 1.03 to 3.30, p = 0.04; alleles: OR 1.68, 95% CI 0.98 to 2.88, p = 0.06). Both polymorphisms were tested for their interactions with sex and the presence of the apolipoprotein E ε4 allele.

Conclusions: The results support the hypothesis for a common genetic aetiology predisposing to insulin resistance and AD.

Full Text

The Full Text of this article is available as a PDF (175.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen N. H., Gordon S., Hope T., Burns A. Manchester and Oxford Universities Scale for the Psychopathological Assessment of Dementia (MOUSEPAD). Br J Psychiatry. 1996 Sep;169(3):293–307. doi: 10.1192/bjp.169.3.293. [DOI] [PubMed] [Google Scholar]
  2. Baier L. J., Wiedrich C., Hanson R. L., Bogardus C. Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes. 1998 Jun;47(6):973–975. doi: 10.2337/diabetes.47.6.973. [DOI] [PubMed] [Google Scholar]
  3. Brady M. J., Printen J. A., Mastick C. C., Saltiel A. R. Role of protein targeting to glycogen (PTG) in the regulation of protein phosphatase-1 activity. J Biol Chem. 1997 Aug 8;272(32):20198–20204. doi: 10.1074/jbc.272.32.20198. [DOI] [PubMed] [Google Scholar]
  4. Craft S., Asthana S., Schellenberg G., Baker L., Cherrier M., Boyt A. A., Martins R. N., Raskind M., Peskind E., Plymate S. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann N Y Acad Sci. 2000 Apr;903:222–228. doi: 10.1111/j.1749-6632.2000.tb06371.x. [DOI] [PubMed] [Google Scholar]
  5. Curb J. D., Rodriguez B. L., Abbott R. D., Petrovitch H., Ross G. W., Masaki K. H., Foley D., Blanchette P. L., Harris T., Chen R. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology. 1999 Mar 23;52(5):971–975. doi: 10.1212/wnl.52.5.971. [DOI] [PubMed] [Google Scholar]
  6. Doré S., Bastianetto S., Kar S., Quirion R. Protective and rescuing abilities of IGF-I and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons. Ann N Y Acad Sci. 1999;890:356–364. doi: 10.1111/j.1749-6632.1999.tb08015.x. [DOI] [PubMed] [Google Scholar]
  7. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  8. Frölich L., Blum-Degen D., Bernstein H. G., Engelsberger S., Humrich J., Laufer S., Muschner D., Thalheimer A., Türk A., Hoyer S. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm (Vienna) 1998;105(4-5):423–438. doi: 10.1007/s007020050068. [DOI] [PubMed] [Google Scholar]
  9. Frölich L., Blum-Degen D., Riederer P., Hoyer S. A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann N Y Acad Sci. 1999;893:290–293. doi: 10.1111/j.1749-6632.1999.tb07839.x. [DOI] [PubMed] [Google Scholar]
  10. Gasparini L., Gouras G. K., Wang R., Gross R. S., Beal M. F., Greengard P., Xu H. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci. 2001 Apr 15;21(8):2561–2570. doi: 10.1523/JNEUROSCI.21-08-02561.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hansen L., Hansen T., Vestergaard H., Bjørbaek C., Echwald S. M., Clausen J. O., Chen Y. H., Chen M. X., Cohen P. T., Pedersen O. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin. Hum Mol Genet. 1995 Aug;4(8):1313–1320. doi: 10.1093/hmg/4.8.1313. [DOI] [PubMed] [Google Scholar]
  12. Hegele R. A., Harris S. B., Zinman B., Wang J., Cao H., Hanley A. J., Tsui L. C., Scherer S. W. Variation in the AU(AT)-rich element within the 3'-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians. J Clin Endocrinol Metab. 1998 Nov;83(11):3980–3983. doi: 10.1210/jcem.83.11.5219. [DOI] [PubMed] [Google Scholar]
  13. Holmes C., Cairns N., Lantos P., Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry. 1999 Jan;174:45–50. doi: 10.1192/bjp.174.1.45. [DOI] [PubMed] [Google Scholar]
  14. Hong M., Lee V. M. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem. 1997 Aug 1;272(31):19547–19553. doi: 10.1074/jbc.272.31.19547. [DOI] [PubMed] [Google Scholar]
  15. Kawanishi M., Tamori Y., Masugi J., Mori H., Ito C., Hansen T., Andersen C. B., Pedersen O., Kasuga M. Prevalence of a polymorphism of the phosphatidylinositol 3-kinase p85 alpha regulatory subunit (codon 326 Met-->Ile) in Japanese NIDDM patients. Diabetes Care. 1997 Jun;20(6):1043–1043. doi: 10.2337/diacare.20.6.1043. [DOI] [PubMed] [Google Scholar]
  16. Kehoe P. G., Russ C., McIlory S., Williams H., Holmans P., Holmes C., Liolitsa D., Vahidassr D., Powell J., McGleenon B. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet. 1999 Jan;21(1):71–72. doi: 10.1038/5009. [DOI] [PubMed] [Google Scholar]
  17. Kuusisto J., Koivisto K., Mykkänen L., Helkala E. L., Vanhanen M., Hänninen T., Kervinen K., Kesäniemi Y. A., Riekkinen P. J., Laakso M. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ. 1997 Oct 25;315(7115):1045–1049. doi: 10.1136/bmj.315.7115.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Liao H., Li Y., Brautigan D. L., Gundersen G. G. Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein Tau. J Biol Chem. 1998 Aug 21;273(34):21901–21908. doi: 10.1074/jbc.273.34.21901. [DOI] [PubMed] [Google Scholar]
  19. Lovestone S., Reynolds C. H. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience. 1997 May;78(2):309–324. doi: 10.1016/s0306-4522(96)00577-5. [DOI] [PubMed] [Google Scholar]
  20. Luchsinger J. A., Tang M. X., Stern Y., Shea S., Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001 Oct 1;154(7):635–641. doi: 10.1093/aje/154.7.635. [DOI] [PubMed] [Google Scholar]
  21. McKeith I. G., Galasko D., Kosaka K., Perry E. K., Dickson D. W., Hansen L. A., Salmon D. P., Lowe J., Mirra S. S., Byrne E. J. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996 Nov;47(5):1113–1124. doi: 10.1212/wnl.47.5.1113. [DOI] [PubMed] [Google Scholar]
  22. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  23. Merrick S. E., Trojanowski J. Q., Lee V. M. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J Neurosci. 1997 Aug 1;17(15):5726–5737. doi: 10.1523/JNEUROSCI.17-15-05726.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mortel K. F., Wood S., Pavol M. A., Meyer J. S., Rexer J. L. Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease. Angiology. 1993 Aug;44(8):599–605. doi: 10.1177/000331979304400802. [DOI] [PubMed] [Google Scholar]
  25. Mustafa A., Lannfelt L., Lilius L., Islam A., Winblad B., Adem A. Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation. Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):446–451. doi: 10.1159/000017188. [DOI] [PubMed] [Google Scholar]
  26. Niikura T., Hashimoto Y., Okamoto T., Abe Y., Yasukawa T., Kawasumi M., Hiraki T., Kita Y., Terashita K., Kouyama K. Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner. J Neurosci. 2001 Mar 15;21(6):1902–1910. doi: 10.1523/JNEUROSCI.21-06-01902.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ott A., Stolk R. P., van Harskamp F., Pols H. A., Hofman A., Breteler M. M. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999 Dec 10;53(9):1937–1942. doi: 10.1212/wnl.53.9.1937. [DOI] [PubMed] [Google Scholar]
  28. Palinkas L. A., Barrett-Connor E., Wingard D. L. Type 2 diabetes and depressive symptoms in older adults: a population-based study. Diabet Med. 1991 Jul;8(6):532–539. doi: 10.1111/j.1464-5491.1991.tb01646.x. [DOI] [PubMed] [Google Scholar]
  29. Palumbo P. J., Elveback L. R., Whisnant J. P. Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol. 1978;19:593–601. [PubMed] [Google Scholar]
  30. Peila Rita, Rodriguez Beatriz L., Launer Lenore J., Honolulu-Asia Aging Study Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes. 2002 Apr;51(4):1256–1262. doi: 10.2337/diabetes.51.4.1256. [DOI] [PubMed] [Google Scholar]
  31. Reaven G. M., Thompson L. W., Nahum D., Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care. 1990 Jan;13(1):16–21. doi: 10.2337/diacare.13.1.16. [DOI] [PubMed] [Google Scholar]
  32. Rockwood K., Ebly E., Hachinski V., Hogan D. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol. 1997 Jan;54(1):33–39. doi: 10.1001/archneur.1997.00550130019010. [DOI] [PubMed] [Google Scholar]
  33. Román G. C., Tatemichi T. K., Erkinjuntti T., Cummings J. L., Masdeu J. C., Garcia J. H., Amaducci L., Orgogozo J. M., Brun A., Hofman A. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993 Feb;43(2):250–260. doi: 10.1212/wnl.43.2.250. [DOI] [PubMed] [Google Scholar]
  34. Roth M., Tym E., Mountjoy C. Q., Huppert F. A., Hendrie H., Verma S., Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986 Dec;149:698–709. doi: 10.1192/bjp.149.6.698. [DOI] [PubMed] [Google Scholar]
  35. Russ C., Powell J., Lovestone S., Holmes C. K variant of butyrycholinesterase and late-onset Alzheimer's disease. Lancet. 1998 Mar 21;351(9106):881–881. doi: 10.1016/S0140-6736(05)70292-0. [DOI] [PubMed] [Google Scholar]
  36. Shen G. Q., Ikegami H., Kawaguchi Y., Fujisawa T., Hamada Y., Ueda H., Shintani M., Nojima K., Kawabata Y., Yamada K. Asp905Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM. Diabetes Care. 1998 Jul;21(7):1086–1089. doi: 10.2337/diacare.21.7.1086. [DOI] [PubMed] [Google Scholar]
  37. Solano D. C., Sironi M., Bonfini C., Solerte S. B., Govoni S., Racchi M. Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J. 2000 May;14(7):1015–1022. doi: 10.1096/fasebj.14.7.1015. [DOI] [PubMed] [Google Scholar]
  38. Stewart R., Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med. 1999 Feb;16(2):93–112. doi: 10.1046/j.1464-5491.1999.00027.x. [DOI] [PubMed] [Google Scholar]
  39. Takadera T., Sakura N., Mohri T., Hashimoto T. Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention. Neurosci Lett. 1993 Oct 14;161(1):41–44. doi: 10.1016/0304-3940(93)90135-8. [DOI] [PubMed] [Google Scholar]
  40. Takezako T., Saku K., Zhang B., Ou J., Bai H., Imai K., Jimi S., Shirai K., Arakawa K. Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris. Am J Hypertens. 1999 Mar;12(3):291–297. doi: 10.1016/s0895-7061(98)00263-5. [DOI] [PubMed] [Google Scholar]
  41. Tanii H., Ankarcrona M., Flood F., Nilsberth C., Mehta N. D., Perez-Tur J., Winblad B., Benedikz E., Cowburn R. F. Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis. Neuroscience. 2000;95(2):593–601. doi: 10.1016/s0306-4522(99)00432-7. [DOI] [PubMed] [Google Scholar]
  42. Terauchi Y., Tsuji Y., Satoh S., Minoura H., Murakami K., Okuno A., Inukai K., Asano T., Kaburagi Y., Ueki K. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat Genet. 1999 Feb;21(2):230–235. doi: 10.1038/6023. [DOI] [PubMed] [Google Scholar]
  43. Weihl C. C., Ghadge G. D., Kennedy S. G., Hay N., Miller R. J., Roos R. P. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci. 1999 Jul 1;19(13):5360–5369. doi: 10.1523/JNEUROSCI.19-13-05360.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Xia J., Scherer S. W., Cohen P. T., Majer M., Xi T., Norman R. A., Knowler W. C., Bogardus C., Prochazka M. A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes. 1998 Sep;47(9):1519–1524. doi: 10.2337/diabetes.47.9.1519. [DOI] [PubMed] [Google Scholar]
  45. Yanagisawa M., Planel E., Ishiguro K., Fujita S. C. Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease. FEBS Lett. 1999 Nov 19;461(3):329–333. doi: 10.1016/s0014-5793(99)01480-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES